Biotech Acquisition Total Current Liabilities

Biotech Acquisition (BIOT) currently reports a total current liabilities of $3.5M as of September 2022. That compares with $360K in the prior-year period — up 881.1% year over year. Use the charts on this page to explore Biotech Acquisition's total current liabilities history and peer comparisons.

Biotech Acquisition's total current liabilities increased from $360K to $3.5M — a 881.1% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biotech Acquisition reported $3.5M in total current liabilities as of September 2022. That compares with $360K in the prior-year period — up 881.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $3.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biotech Acquisition, and consider following BIOT for alerts when major investors trade the stock.